Загрузка...
Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline
1. Selegiline is used for treating Parkinson's disease. Despite its efficacy, the clinical use of selegiline in combination with L-dihydroxphenylalanine in Parkinsonian patients is hampered by cardiovascular complications, such as hypotension. This study was designed to compare in rats the card...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2004
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1575354/ https://ncbi.nlm.nih.gov/pubmed/15339864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705962 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|